These results indicated that IFN-γ transfection of human NB cells may achieve not only activation of immune antitumour responses, as already demonstrated by others, but also affect NB tumour growth per se, by inhibiting NB proliferation and exploiting an antiangiogenic effect. The gene discussed is IFNG; the disease is neuroblastoma.